Cisplatin Activates the Growth Inhibitory Signaling Pathways by Enhancing the Production of Reactive Oxygen Species in Non-small Cell Lung Cancer Carrying an EGFR Exon 19 Deletion

Md Mohiuddin(Southeast University), Kazuo Kasahara(Nippon Medical School)

Cancer Genomics & Proteomics

January 1, 2021

10.21873/cgp.20273

Cited by 13

Related Papers

Paclitaxel Impedes EGFR-mutated PC9 Cell Growth<i>via</i>Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression

|Cancer Genomics & Proteomics|2021|27

The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells

|Cancer Genomics & Proteomics|2021|18

Cisplatin and Pemetrexed Have Distinctive Growth-inhibitory Effects in Monotherapy and Combination Therapy on<i>KRAS</i>-dependent A549 Lung Cancer Cells

|Cancer Genomics & Proteomics|2021|8

Pemetrexed Disodium Heptahydrate Induces Apoptosis and Cell-cycle Arrest in Non-small-cell Lung Cancer Carrying an EGFR Exon 19 Deletion

|Anticancer Research|2021|6